Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Clinical trial NCT06625190 · RECRUITING

Trial details

NCT number: NCT06625190
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Rhabdomyosarcoma Synovial Sarcoma Peripheral Nerve Sheath Tumors Clear Cell Sarcoma Alveolar Soft Part Sarcoma Desmoplastic Small Round Cell Tumor Chordoma Rhabdoid Tumor Epithelioid Sarcoma Myoepithelial Tumor Osteosarcoma

Start date: 2026-02-11
Primary completion: 2030-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.